Therapeutic Use of Stem Cells for Myocardial Infarction

Myocardial infarction is a leading cause of morbidity and mortality worldwide. Although medical and surgical treatments can significantly improve patient outcomes, no treatment currently available is able to generate new contractile tissue or reverse ischemic myocardium. Driven by the recent/novel u...

Descripción completa

Detalles Bibliográficos
Autores principales: Madigan, Mariah, Atoui, Rony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027340/
https://www.ncbi.nlm.nih.gov/pubmed/29642402
http://dx.doi.org/10.3390/bioengineering5020028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027340/
https://www.ncbi.nlm.nih.gov/pubmed/29642402
http://dx.doi.org/10.3390/bioengineering5020028

Ejemplares similares